Market News & Trends
Boehringer Ingelheim’s Investigational Asset Delivers Proteinuria Reduction in Phase II Kidney Trial
Boehringer Ingelheim today announced results from a 12-week Phase II clinical trial evaluating apecotrep (BI 764198), an oral, potential first-in-class, non-immunosuppressive TRPC6 inhibitor for people…
Halo Pharma to Become a Stand-Alone Drug Product Contract Development & Manufacturing Organization
Halo Pharma, a leading CDMO specializing in drug product pharmaceutical development and manufacturing services, will become a stand-alone business as a result of the sale…
Argo Biopharma Announces First Patient Dosed in Phase 2b Trial of siRNA Therapeutic in Patients with Elevated Lp(a)
Argo Biopharmaceutical Co., Ltd. recently announced the first patient has been dosed in a global Phase 2b clinical trial sponsored by Novartis evaluating DII235, also…
Vortex Biotech Opens New State-of-the-Art Laboratory at Manchester Science Park
Vortex Biotech Holdings Limited has announced the opening of its advanced laboratory facilities at Manchester Science Park. The new site significantly enhances the company’s R&D…
Nanexa Announces Breakthrough Preclinical Data Demonstrating Exceptional Pharmacokinetic Profile for Monthly Semaglutide Formulation
Nanexa AB recently announced exceptional preclinical results for its long-acting semaglutide formulation developed using the company’s proprietary PharmaShell drug delivery platform. PharmaShell encases active pharmaceutical…
iXCells Biotechnologies & Rosebud Biosciences Partner to Advance Organoid-Based Models for Rare Diseases
iXCells Biotechnologies and Rosebud Biosciences recently announced a partnership to develop a personalized, human-based approach for predicting drug safety and informing translational decision-making in rare…
Medicus Pharma Announces Amendment to LifeArc License Improving Teverelix Long-Term Economic & Development Profile
Medicus Pharma Ltd. recently announced its subsidiary, Antev Ltd., has entered into Amendment No. 3 to its license agreement with LifeArc relating to Teverelix, an investigational next generation long-acting GnRH…
Dosing Completed in the Phase I Clinical Trial of PulseSight Therapeutics’ Treatment for Dry AMD/Geographic Atrophy
PulseSight Therapeutics SAS recently announced the completion of PST-611 Phase I clinical trial enrolment. Trial data will be presented at the 2026 ARVO Annual Meeting…
Mendra Launches With $82 Million to Acquire, Develop & Commercialize Therapeutics for High Unmet Need Rare Diseases
Mendra, Inc. recently announced its launch in conjunction with the closing of an $82 million oversubscribed Series A financing. The round was co-led by OrbiMed, 8VC,…
Datwyler Launches Industry’s First 20mL Universal Plunger for Large-Volume On-Body Delivery
Datwyler, a leading provider of high-quality, system-critical elastomer components, expanded its NeoFlex range of fully coated plungers with a solution for large-volume cartridges containing 20mL.…
Vetter Achieves Top Sustainability Rating & Expands Climate Goal Commitments
Vetter has strengthened its sustainability strategy with distinguished recognitions: the internationally renowned EcoVadis Platinum rating as well as the official validation of its emission reduction…
Nemera’s Multi-Dose Eyedropper for Preservative-Free Formulations Approved With Haohai Qisheng for Dry Eye in China
Shanghai HaoHai have launched their product, Lubricant eyedrops, Eyesucom® 隐形眼镜润眼液 with Novelia® 15mL dispenser, specifically designed to hydrate and lubricate the ocular surface, providing relief…
Sharp Services Makes Significant Investment to Expand Injectables Packaging Capacity at its European Facilities
Sharp Services recently announced it has invested over €20 million in its European packaging facilities in response to strong market demand in the injectables market.…
Levicept Announces FDA Acceptance of IND Application for LEVI-04, a Potentially Disease-Modifying Treatment for Osteoarthritis
Levicept Ltd recently announced the US FDA has accepted its Investigational New Drug (IND) application for LEVI-04. This enables the initiation of further clinical development…
Brainomix e-Lung AI Imaging Technology Selected as Co-Primary Endpoint in Boehringer Ingelheim Phase 3 Clinical Trial in Pulmonary Fibrosis
Brainomix recently announced it was selected by Boehringer Ingelheim, the leading biopharmaceutical company providing therapeutic options for interstitial lung disease (ILD), to provide objective, quantitative HRCT…
Sever Pharma Solutions Announces Appointment of New VP of Quality
Sever Pharma Solutions (SPS) recently announce the appointment of Niklas Lindgren as the company’s new Vice President of Quality, effective January 19, 2026. The appointment…
Copley Scientific Launches New Platform for Inhaled Product Testing
The innovative Inhaled Dissolution Apparatus (IDA) from Copley Scientific introduces discriminating dissolution testing to the commercially available in vitro toolkit for inhaled drug products. Addressing a…
Proveris Joins Investindustrial to Support Customers & Long-Term Growth
Proveris Scientific, a leading provider of instrumentation and services to advance the science of aerosol and spray products, today announced that it has been acquired…
Gattefossé Advances Integrated Water Management Across All Industrial Operations in France
Gattefossé, a leading supplier of specialty ingredients for the beauty and health industries, is strengthening its environmental performance through Poseidon, a cross-functional program that integrates…
Datwyler, LTS Device Technologies & Stevanato Group Collaborate to Expand Self-Delivery Options for Large-Volume Drugs
Datwyler recently announced a collaboration with LTS Device Technologies, a developer of smart wearable devices for drug delivery, and Stevanato Group, a leading global provider…
